Report for: Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial

Title	Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial
Published by	Springer Nature, May 2015
DOI	10.1186/s13063-015-0731-0
Pubmed ID	25982544
Authors	Annalisa Casarin, Daniel F McAuley, Timothy M Alce, Xiaobei Zhao, E Wesley Ely, Jim C Jackson, Cliona McDowell, Ashley Agus, Lynn Murphy, Valerie J Page

X Demographics

The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.

Type	Count	As %
Members of the public	20	74%
Practitioners (doctors, other healthcare professionals)	3	11%
Science communicators (journalists, bloggers, editors)	2	7%
Scientists	2	7%

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Netherlands	1	<1%
Unknown	126	99%

Readers by professional status	Count	As %
Student > Master	21	17%
Researcher	15	12%
Student > Ph. D. Student	13	10%
Student > Bachelor	10	8%
Student > Postgraduate	10	8%
Other	25	20%
Unknown	33	26%

Readers by discipline	Count	As %
Medicine and Dentistry	42	33%
Nursing and Health Professions	13	10%
Neuroscience	7	6%
Psychology	6	5%
Engineering	4	3%
Other	20	16%
Unknown	35	28%

Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study…